Similar articles

• Beta-cell dysfunction in subjects with impaired glucose tolerance and early type 2 diabetes: comparison of surrogate markers with first-phase insulin secretion from an intravenous glucose tolerance test.

  Festa A, Williams K, Hanley AJ, Haffner SM. Festa A, et al. Diabetes. 2008 Jun;57(6):1638-44. doi: 10.2337/db07-0954. Epub 2008 Mar 10. Diabetes. 2008. PMID: 18332099
• Insulin deficiency rather than hyperinsulinaemia in newly diagnosed type 2 diabetes mellitus.

  Davies MJ, Metcalfe J, Gray IP, Day JL, Hales CN. Davies MJ, et al. Diabet Med. 1993 May;10(4):305-12. doi: 10.1111/j.1464-5491.1993.tb00070.x. Diabet Med. 1993. PMID: 8508611
• Increased proinsulin levels and decreased acute insulin response independently predict the incidence of type 2 diabetes in the insulin resistance atherosclerosis study.

  Hanley AJ, D'Agostino R Jr, Wagenknecht LE, Saad MF, Savage PJ, Bergman R, Haffner SM; Insluin Resistance Atrherosclerosis Study. Hanley AJ, et al. Diabetes. 2002 Apr;51(4):1263-70. doi: 10.2337/diabetes.51.4.1263. Diabetes. 2002. PMID: 11916954
• Insulin resistance and beta-cell dysfunction as therapeutic targets in type 2 diabetes.

  Evans AJ, Krentz AJ. Evans AJ, et al. Diabetes Obes Metab. 2001 Aug;3(4):219-29. doi: 10.1046/j.1463-1326.2001.00101.x. Diabetes Obes Metab. 2001. PMID: 11520301 Review. No abstract available.
• Islet-cell abnormalities in non-insulin-dependent diabetes mellitus.

  Raskin P. Raskin P. Am J Med. 1985 Aug 23;79(2B):2-5. doi: 10.1016/0002-9343(85)90578-9. Am J Med. 1985. PMID: 3898829 Review.